The Effect of Body Posture on Intraocular Pressure in Progressive Glaucoma
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Graham Prof Trope, PhD, FRCSC
- Phone Number: 4166035317
- Email: Graham.Trope@uhn.on.ca
Study Contact Backup
- Name: Yvonne Prof Buys, MD, FRCSC
- Phone Number: 4166035682
- Email: y.buys@utoronta.ca
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5T 2S8
- Recruiting
- Toronto Western Hospital
-
Contact:
- Graham Prof Trope, PhD, FRCSC
- Phone Number: 4166035317
- Email: raham.Trope@uhn.on.ca
-
Principal Investigator:
- Graham E Trope, PhD, FRCSC
-
Sub-Investigator:
- Yvonne M Buys, MD, FRCSC
-
Sub-Investigator:
- Hussain Patel, MD
-
Sub-Investigator:
- John Flanagan, DO, PhD
-
Sub-Investigator:
- Colin Shapiro, MD, PhD
-
Sub-Investigator:
- Farzana Jahan, MD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- signed informed consent
- diagnosis of primary open angle glaucoma (POAG) or normal tension glaucoma (NTG) that is progressing based on recent or recurrent optic disc hemorrhage
- age 18-85 years
- not more than 4 diopters of spherical equivalent or 2 diopters of cylinder equivalent in study eye
- stable anti-glaucoma treatment for 4 weeks before first session
- for women of childbearing potential, adequate contraception
Exclusion Criteria:
- unwilling or unable to sleep in a flat or 30 degrees head up position
- ocular surgery in previous 3 months
- corneal or conjunctival abnormality
- wear of full frame metallic glasses during monitoring session
- severe dry eye
- secondary forms of glaucoma
- allergy to corneal anaesthesia
- patients with contraindications for contact lens wear
- pregnancy and lactation
- patients unable to understand the character and individual consequences of the investigation
- simultaneous participation in other research
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Progressive glaucoma
Patients with primary open angle glaucoma identified to have an optic disc hemorrhage
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intraocular pressure changes that occur during sleep and with changes in body posture
Time Frame: 24 hours
|
The intraocular pressure will be continuously monitored with a wireless contact lens sensor device over a 24 hour period
|
24 hours
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of side effects or adverse effects that occur while subjects are wearing the contact lens device
Time Frame: 24 hours
|
Patients will be monitored for contact lens related side effects or adverse effects that occur during the monitoring session.
|
24 hours
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 10-0844-A
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.